Cost-effectiveness of pneumococcal vaccines among adults over 50 years old in low- and middle-income countries: a systematic review-Reference-Cited by-同舟云学术

Cost-effectiveness of pneumococcal vaccines among adults over 50 years old in low- and middle-income countries: a systematic review

Published:2020-12-01 Issue:12 Volume:19 Page:1141-1151
ISSN:1476-0584
Container-title:Expert Review of Vaccines
language:en
Short-container-title:Expert Review of Vaccines

Author:

Shao Yixue¹^ORCID,Stoecker Charles¹

Affiliation:

1. Department of Health Policy and Management, Tulane University School of Public Health and Tropical Medicine, New Orleans, LA, USA

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmacology,Molecular Medicine,Immunology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14760584.2020.1874929

Reference52 articles.

1. Estimating the Burden of Pneumococcal Pneumonia among Adults: A Systematic Review and Meta-Analysis of Diagnostic Techniques

2. Pneumococcal Vaccination Strategies. An Update and Perspective

3. Dadonaite B, Roser M. Pneumonia [Internet]. Our World Data. 2019 [cited 2020 May 10]. Available from: https://ourworldindata.org/pneumonia#licence.

4. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A cost-effectiveness analysis of the 13-valent pneumococcal conjugated vaccine and the 23-valent pneumococcal polysaccharide vaccine among Thai older adult;Frontiers in Public Health;2023-06-29

2. Incidence and risk factors of pneumococcal pneumonia in adults: a population-based study;BMC Pulmonary Medicine;2023-06-08

3. Herd immunity in older adults from a middle‐income country: A time‐series trend analysis of community‐acquired pneumonia mortality 2003–2017;Health Science Reports;2023-05

4. Evaluating clinical effectiveness and impact of anti-pneumococcal vaccination in adults after universal childhood PCV13 implementation in Catalonia, 2017–2018;Vaccine: X;2023-04

5. Economic evaluations of 13-valent pneumococcal conjugate vaccine: a systematic review;Expert Review of Vaccines;2023-02-09